29 results
6-K
EX-10.2
ACIU
AC Immune SA
4 Aug 21
Current report (foreign)
7:21am
6-K
EX-10.1
ACIU
AC Immune SA
4 Aug 21
Current report (foreign)
7:21am
6-K
EX-10.3
ACIU
AC Immune SA
4 Aug 21
Current report (foreign)
7:21am
6-K
EX-10.1
ACIU
AC Immune SA
23 Mar 20
AC Immune Receives Second Milestone and New Milestone to Increase the Potential Deal Value of Lilly Morphomerâ„¢ Tau Partnership
8:15am
6-K
EX-10.1
ACIU
AC Immune SA
20 Sep 19
AC Immune Receives First Milestone Payment from Lilly in Small Molecule Tau Morphomerâ„¢ Program
7:53am
F-1/A
EX-10.5
nygj442k
13 Sep 16
Registration statement (foreign) (amended)
12:00am
F-1/A
EX-10.3
27pxhp9skyih0
13 Sep 16
Registration statement (foreign) (amended)
12:00am
F-1
EX-10.1
323lsg
31 May 16
Registration statement (foreign)
12:00am
F-1
EX-10.4
vf4oni8ps7w r9
31 May 16
Registration statement (foreign)
12:00am
F-1
EX-10.9
opoz0p4ntn705fjaes
31 May 16
Registration statement (foreign)
12:00am
F-1
EX-10.8
mcf15qn4f3y5697 3w
31 May 16
Registration statement (foreign)
12:00am
F-1
EX-10.2
q25 ir5fy6raf
31 May 16
Registration statement (foreign)
12:00am
F-1
EX-10.7
yf18 5e2wkyfgai
31 May 16
Registration statement (foreign)
12:00am
F-1
EX-10.3
wavjt5xeqf
31 May 16
Registration statement (foreign)
12:00am
F-1
EX-10.6
ehg 4q5sca8gzmo6qg0
31 May 16
Registration statement (foreign)
12:00am
F-1
EX-10.5
mw0q3jh1nj igxwmv
31 May 16
Registration statement (foreign)
12:00am
DRS/A
EX-10.5
ffa7pkfq
24 Nov 15
Draft registration statement (amended)
12:00am
DRS/A
EX-10.1
6lu2dw
24 Nov 15
Draft registration statement (amended)
12:00am
DRS/A
EX-10.3
3404x g78p6
24 Nov 15
Draft registration statement (amended)
12:00am
DRS/A
EX-10.4
hw10 8kxb5
24 Nov 15
Draft registration statement (amended)
12:00am